Navigation Links
Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance
Date:3/12/2010

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate in development for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhibitor, RDEA684, is currently in preclinical development. RDEA119, a potent and specific inhibitor of mitogen-activated ERK kinase (MEK), is being developed under a global license agreement with Bayer HealthCare AG. RDEA119 is currently being evaluated in advanced cancer patients with different tumor types as a single agent in a Phase 1 study, as well as in combination with sorafenib (Nexavar®, Bayer HealthCare, Onyx Pharmaceuticals, Inc.) in a Phase 1/2 study. RDEA806, for the treatment of HIV, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that has successfully completed a Phase 2a study in HIV patients. RDEA427, a next generation NNRTI, has superior pharmacokinetic properties, and even greater activity against a wide range of drug-resistant viral isolates than RDEA806. We have evaluated RDEA427 in a human micro-dose pharmacokinetic study.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" with
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... "Global Pulse Oximeter Industry Report 2014" report ... Oximeter Industry Report 2014 is a professional and in-depth ... oximeter industry. The report provides a basic ... industry chain structure. The pulse oximeter market analysis is ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Pulse Oximeter Industry Report 2014 2
(Date:8/27/2014)... York (PRWEB) August 27, 2014 The ... ( http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline for plaintiffs ... an August 2014 Order issued by U.S. District Judge ... wishing to enroll in the DePuy ASR Settlement Program ... DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation ...
(Date:8/27/2014)... 2014 The extensive polling of ... healthcare research group Black Book Rankings uncovers several ... staffed, supplied or built to care for even ... this annual survey to gain stakeholder insight into ... epidemiology and emergency preparedness systems,” said Doug Brown, ...
(Date:8/27/2014)... Ticket Down is a dependable source for authentic Brazil ... The Brazilian national soccer team will tangle with the ... Stadium in Miami Gardens, Florida. The two South American ... earlier this year when Brazil got the 2-1 win, but ... announced earlier this week that Neymar would return from injury ...
(Date:8/27/2014)... (HealthDay News) -- There,s been controversy for years over ... their pregnancies might raise the odds of mental health ... more than 13,000 children finds no rise in the ... an antidepressant while pregnant, but some data suggesting a ... The findings challenge prior research pointing to a ...
(Date:8/27/2014)... Chicago, Illinois (PRWEB) August 27, 2014 ... the 2014 FIBA World Cup in Spain at ... in their role as FIBA Equipment & Venue Centre Partner ... to 2016. , The six courts will bear the Connor ... by fans around the globe on the ESPN broadcasts of ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 2Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 3Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3
... high risk of suffering a stroke, say US researchers. They ... opticians and GPs to mass-screen patients.Strokes are caused by brain ... that are effective at preventing stroke in high-risk patients are ... to their network of blood vessels - their vascular system ...
... have increased risk of stroke due to elevated cholesterol. Much ... stroke has concentrated on men. Now doctors at Columbia University ... of stroke. They looked at over 20,000 women with no ... from 30 to 95 years. The women were followed up ...
... a recent study, spending time in an Indian temple improves ... new study, India, looked at how traditional healing practices might ... South India has long been a healing centre for those ... short period in 1000 were enrolled in the study. ...
... on African tribe, most of the things being equal including ... be healthier for the heart than eating a vegetarian diet. ... body control blood levels of leptin,// a substance secreted by ... risk for heart attack and stroke. ,Lead author of ...
... that high levels of the amino acid homocysteine may ... disease, researchers report. It is still too soon to ... risk of Alzheimer's// and other types of dementia, but ... shown that elevated levels of homocysteine may increase the ...
... darkness might prevent retinal damage in diabetes. One of the ... diabetic retinopathy. This results from damage to the retina //- ... which responds to light.In diabetes, the blood supply to the ... rods (the cells responsible for night vision) which have a ...
Cached Medicine News:Health News:Fish rich diet lowers leptin 2Health News:High Levels of Protein Linked to Brain Shrinkage 2
Cold light source single outlet....
Cold light source single outlet....
Cold light source triple outlet....
Cold light source triple outlet....
Medicine Products: